| 000 | 01825 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516210530.0 | ||
| 264 | 0 | _c20141206 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1471-2369 | ||
| 024 | 7 |
_a10.1186/1471-2369-15-65 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHernández, Domingo | |
| 245 | 0 | 0 |
_aRegression of cardiac growth in kidney transplant recipients using anti-m-TOR drugs plus RAS blockers: a controlled longitudinal study. _h[electronic resource] |
| 260 |
_bBMC nephrology _cApr 2014 |
||
| 300 |
_a65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin Receptor Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xdiagnosis |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRuiz-Esteban, Pedro | |
| 700 | 1 | _aGaitán, Daniel | |
| 700 | 1 | _aBurgos, Dolores | |
| 700 | 1 | _aMazuecos, Auxiliadora | |
| 700 | 1 | _aCollantes, Rocío | |
| 700 | 1 | _aBriceño, Eva | |
| 700 | 1 | _aPalma, Eulalia | |
| 700 | 1 | _aCabello, Mercedes | |
| 700 | 1 | _aGonzález-Molina, Miguel | |
| 700 | 1 | _aDe Mora, Manuel | |
| 773 | 0 |
_tBMC nephrology _gvol. 15 _gp. 65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2369-15-65 _zAvailable from publisher's website |
| 999 |
_c23758962 _d23758962 |
||